Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Kobayashi Pharmaceutical (4967.T)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (¥) Price Target (¥) Rating
2021-08-13859013200Buy
2021-11-16938013100Buy
2022-03-01975012600Buy
2022-04-28889011600Buy
2022-09-06802011500Buy
2023-03-07824011000Buy
2023-06-07802110900Buy
2023-09-01722710400Buy
2024-05-0253805900Neutral
2024-09-3057035700Neutral

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.